Opko Health Inc (OPK)

May 04, 2025

Marshall Wace LLP Has $1.36 Million Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

May 04, 2025

May 04, 2025

Invesco Ltd. Has $2.29 Million Stake in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

May 04, 2025

May 03, 2025

Opko health outlines $675M-$685M revenue guidance for 2025 amid strategic initiatives - MSN

May 03, 2025

May 02, 2025

OPKO Health, Inc. (NASDAQ:OPK) Q1 2025 Earnings Call Transcript - Insider Monkey

May 02, 2025

May 02, 2025

Weekly CEO Buys Highlight - GuruFocus

May 02, 2025

May 02, 2025

Labcorp Holdings Inc, BioReference Health, OPKO Health, Inc. - Olean Times Herald

May 02, 2025

May 02, 2025

OPKO Health, Inc. (NASDAQ:OPK) Short Interest Update - MarketBeat

May 02, 2025

May 01, 2025

OPKO Health’s Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks

May 01, 2025

May 01, 2025

OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands - Yahoo Finance

May 01, 2025

May 01, 2025

Quote - OPKO Health, Inc.

May 01, 2025

May 01, 2025

OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... By GuruFocus - Investing.com Canada

May 01, 2025

May 01, 2025

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt - simplywall.st

May 01, 2025

May 01, 2025

OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... - Yahoo Finance

May 01, 2025

May 01, 2025

Earnings call transcript: Opko Health misses Q1 2025 earnings forecast By Investing.com - Investing.com South Africa

May 01, 2025

May 01, 2025

OPKO Health Reports Q1 2025 Financial Highlights - TipRanks

May 01, 2025

Apr 30, 2025

OPKO Health: Q1 Earnings Snapshot - MySA

Apr 30, 2025

Apr 30, 2025

OPKO Health Inc Q1 2025 Earnings: EPS Misses at -$0.10, Revenue Falls Short at $149.9 Million - GuruFocus

Apr 30, 2025

Apr 30, 2025

OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say - Nasdaq

Apr 30, 2025

Apr 30, 2025

OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Apr 30, 2025

Apr 30, 2025

Earnings call transcript: Opko Health misses Q1 2025 earnings forecast - Investing.com

Apr 30, 2025

Apr 30, 2025

Opko Health earnings missed by $0.01, revenue fell short of estimates - Investing.com

Apr 30, 2025

Apr 30, 2025

OPKO Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Apr 30, 2025

Apr 30, 2025

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results - GlobeNewswire

Apr 30, 2025

Apr 30, 2025

OPKO Health (NASDAQ:OPK) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat

Apr 30, 2025

Apr 28, 2025

OPKO Health (OPK) to Release Earnings on Wednesday - MarketBeat

Apr 28, 2025

Apr 28, 2025

Pediatric Growth Hormone Deficiency Treatment Market Size - openPR.com

Apr 28, 2025

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 25, 2025

JP Morgan Initiates Coverage of OPKO Health (OPK) with Neutral Recommendation - MSN

Apr 25, 2025

Apr 25, 2025

Analyst Expectations For OPKO Health's Future - Benzinga

Apr 25, 2025

Apr 25, 2025

JPMorgan starts Opko Health stock with Neutral rating By Investing.com - Investing.com India

Apr 25, 2025

Apr 25, 2025

This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday - Benzinga

Apr 25, 2025

Apr 25, 2025

JPMorgan Initiates OPKO Health at Neutral - marketscreener.com

Apr 25, 2025

Apr 23, 2025

Esoteric Testing Market Generated Opportunities, Future Scope - openPR.com

Apr 23, 2025

Apr 22, 2025

Altshuler Shaham Ltd Buys New Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Apr 22, 2025

Apr 22, 2025

Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a Turnaround - Yahoo Finance

Apr 22, 2025

Apr 20, 2025

OPKO Health Target of Unusually Large Options Trading (NASDAQ:OPK) - MarketBeat

Apr 20, 2025

Apr 18, 2025

Norges Bank Acquires Shares of 1,127,468 OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Apr 18, 2025

Apr 17, 2025

Bone Cancer Drugs Market Deep Research 2025-2032 | Advaxis, Inc., Cellectar Biosciences, Inc., OPKO Health, Inc. - openPR.com

Apr 17, 2025

Apr 17, 2025

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025 - GlobeNewswire

Apr 17, 2025